News Articles Tagged: Pacritinib Oncology

Exploring the Future: Pacritinib's Impact on Targeted Oncology Drug Development

Discusses how Pacritinib's success in myelofibrosis research paves the way for further advancements in targeted oncology drug development.

The Clinical Advantage: Understanding Pacritinib's Role in Myelofibrosis

Delve into the detailed clinical efficacy and safety of Pacritinib, a vital JAK2/FLT3 inhibitor, for patients battling myelofibrosis, especially those with thrombocytopenia.